lung cancer – Patient Worthy

ImmunityBio Reports Encouraging Evidence That ANKTIVA Enhances Immune Recovery in NSCLC When Paired With Checkpoint Inhibitors

Post author:Austin Newman
Post published:January 22, 2026
Post category:non-small cell lung cancer

As reported on Business Wire, ImmunityBio has released new clinical findings suggesting that its interleukin‑15 superagonist, ANKTIVA® (nogapendekin alfa inbakicept), may help restore immune function and improve survival outcomes in…

AstraZeneca’s LATIFY Trial Misses Primary Endpoint in Previously Treated Advanced NSCLC

Post author:Austin Newman
Post published:January 20, 2026
Post category:non-small cell lung cancer

As reported on PharmaBiz, AstraZeneca’s phase III LATIFY trial has fallen short of its primary objective, with the combination of the ATR inhibitor ceralasertib and the PD‑L1 inhibitor Imfinzi (durvalumab)…

Overall Survival Nearly Doubles in Immuneering’s Midstage Pancreatic Cancer Trial

Post author:Rose Duesterwald
Post published:October 8, 2025
Post category:Pancreatic Cancer

Immuneering’s midstage pancreatic deep cyclic MEK protein inhibitor, (DCI), almost doubled the standard overall survival. It is a deep cycle inhibitor that targets key pathways in a pulsed manner. Results…

Corticosteroids May Undermine Immunotherapy Success in Lung Cancer Patients

Post author:Bree Clare
Post published:July 10, 2025
Post category:Lung Cancer

A new study has found that corticosteroids, commonly used to manage symptoms in lung cancer patients, may reduce the effectiveness of immunotherapy treatments. The research, highlighted by News-Medical.net, sheds light…

May’s Lung Cancer Story: “I Never Thought It Would Be Me — But Here I Am (And God Was There All Along)”

Post author:Patient Worthy Contributor
Post published:July 2, 2025
Post category:Lung Cancer

My name is May, and I was diagnosed with lung cancer in May of 2022. I was 37 years old — a wife, a mother to a toddler, and someone…

How Laura Got Her Life Back: The Impact of Organ Donation

Post author:Patient Worthy Contributor
Post published:May 9, 2025
Post category:Rare Disease

Let’s start at the beginning of my long journey. My name is Laura, and around fifteen years ago, I was diagnosed with type-2 diabetes and prescribed medication to control it.…

source: shutterstock.com

November is Lung Cancer Awareness Month

Post author:James Moore
Post published:November 3, 2023
Post category:Lung Cancer Small cell lung cancer

The month of November is recognized around the world as Lung Cancer Awareness Month, a time to advocate and spread awareness about lung cancer. This form of cancer is not…

source: shutterstock.com

Adagrasib Shows Promise in Treating KRAS G12C-Mutated NSCLC

Post author:Jessica Lynn
Post published:October 24, 2023
Post category:non-small cell lung cancer

The 2023 World Conference on Lung Cancer took place from September 9-12 this year. During the conference, stakeholders came together to discuss novel research, emerging trends, and other needs…

kalhh / Pixabay

A Combination of Benmelstobart, Anlotinib, and Chemotherapy Improves Survival Rates in SCLC, Study Suggests

Post author:Jessica Lynn
Post published:October 16, 2023
Post category:Small cell lung cancer

Advancing patient outcomes hinges on the development of targeted treatments, particularly in conditions with grim prognoses such as small cell lung cancer (SCLC), which typically has a life expectancy…

source: pixabay.com

FDA to Review Atezolizumab for the Treatment of Non-Small Cell Lung Cancer

Post author:Kendall Mason
Post published:March 12, 2020
Post category:Cancer

Roche has recently been granted priority review by the FDA, who has also accepted their supplemental biologics license application for atezolizumab. Atezolizumab is intended for the treatment of non-small cell…

stevepb / Pixabay

IMFINZI Shows Efficacy for Stage IV Non-Small Cell Lung Cancer

Post author:James Moore
Post published:November 4, 2019
Post category:Cancer

According to a story from us.acrofan.com, the biopharmaceutical company AstraZeneca recently announced the release of positive results for a clinical trial testing the company's drug durvalumab (marketed as IMFINZI) in…

Source: Pixabay

Study Suggests How Some Lung Cancers Might “Beat” Chemo

Post author:Scott Carlson
Post published:September 25, 2019
Post category:Rare Disease

According to a publication from Augusta University, a recent study lung cancer patients receiving chemotherapy provided a possible explanation for some cancers' ability to resist treatment. The research, conducted by…

New Partnership will Improve and Accelerate Patient Involvement in Lung Cancer Research

Post author:Trudy Horsting
Post published:March 22, 2019
Post category:Adenocarcinoma of lung Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer

Pattern.Org Pattern.org was created by the Rare Cancer Research Foundation, a nonprofit dedicated to improving the lives of rare cancer patients by accelerating research. Pattern.org specifically, is a branch of…

Source: Pixabay.com

Positive Clinical Trial Results for MET Mutated NSCLC!

Post author:Trudy Horsting
Post published:October 30, 2018
Post category:Rare Disease

NSCLC Non-small cell lung cancer or NSCLC is the most common kind of lung cancer diagnosis. It affects over 2 million people and of those, there's a small group who…

Source: Pixabay

The Diggs Family Shares Their Story to Aid in Cancer Prevention

Post author:Trudy Horsting
Post published:October 26, 2018
Post category:Pancreatic Cancer

For some fortunate individuals, cancer is kind of a foreign concept. They obviously know what it is- they hear cancer stories in passing, they may have donated to a charity…

Promising Results for Early Detection of Lung Cancer From New Blood Tests

Post author:Samuel Sachs
Post published:September 6, 2018
Post category:Cancer

According to a report by American Health and Drug Benefits, a new blood test may change cancer screening. The new test would allow for earlier detection than current techniques. Supporting…

Source: Pixabay.com

There’s More Than One Way to Treat Cancer

Post author:Dawn Scott
Post published:July 21, 2018
Post category:Cancer

In an Article from AsiaOne.com, we meet John Ryan, retired nuclear reactor specialist who worked for the military when he was diagnosed with lung cancer. Now in remission he might…

PDPics / Pixabay

A Large-Scale Study on Chemotherapy Identifies Risk Factors For Patients

Post author:Anna Hewitt
Post published:May 22, 2018
Post category:Cancer

A recent study published in the Lancet has investigated the effects of starting chemotherapy on patient survival, according to the UK Government website. It was found that many factors can…

ImmunityBio Reports Encouraging Evidence That ANKTIVA Enhances Immune Recovery in NSCLC When Paired With Checkpoint Inhibitors

AstraZeneca’s LATIFY Trial Misses Primary Endpoint in Previously Treated Advanced NSCLC

Overall Survival Nearly Doubles in Immuneering’s Midstage Pancreatic Cancer Trial

Corticosteroids May Undermine Immunotherapy Success in Lung Cancer Patients

May’s Lung Cancer Story: “I Never Thought It Would Be Me — But Here I Am (And God Was There All Along)”

How Laura Got Her Life Back: The Impact of Organ Donation

November is Lung Cancer Awareness Month

Adagrasib Shows Promise in Treating KRAS G12C-Mutated NSCLC

A Combination of Benmelstobart, Anlotinib, and Chemotherapy Improves Survival Rates in SCLC, Study Suggests

FDA to Review Atezolizumab for the Treatment of Non-Small Cell Lung Cancer

IMFINZI Shows Efficacy for Stage IV Non-Small Cell Lung Cancer

Study Suggests How Some Lung Cancers Might “Beat” Chemo

New Partnership will Improve and Accelerate Patient Involvement in Lung Cancer Research

Positive Clinical Trial Results for MET Mutated NSCLC!

The Diggs Family Shares Their Story to Aid in Cancer Prevention

Promising Results for Early Detection of Lung Cancer From New Blood Tests

There’s More Than One Way to Treat Cancer

A Large-Scale Study on Chemotherapy Identifies Risk Factors For Patients

Let’s Work Together!

Keep Up to Date

Learn More